{"id":"W2099818449","doi":"10.1093/annonc/mdq430","title":"First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Roche","keywords":"Medicine; Bevacizumab; Taxane; Metastatic breast cancer; Internal medicine; Docetaxel; Oncology; Clinical endpoint; Neutropenia; Chemotherapy; Breast cancer; Population; Surgery; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001647899,0.001105115,0.003109118,0.0006965784,0.0004786888,0.001180639,0.000775918,0.000780221,0.002122988],"category_scores_gemma":[0.001066775,0.0006037062,0.001889828,0.0007134948,0.001095034,0.0008046907,0.000350976,0.002486909,0.0005355765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001430069,"about_ca_system_score_gemma":0.001391043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00243735,"about_ca_topic_score_gemma":0.005204625,"domain_scores_codex":[0.999356,0.0002772218,0.00003559074,0.0001416559,0.00007469697,0.0001148379],"domain_scores_gemma":[0.9991862,0.0001699809,0.0002000303,0.00008501885,0.00004695218,0.0003118238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8240354,0.04324727,0.02120124,0.0008410491,0.003276501,0.0002239943,0.0003595096,0.00148149,0.01454921,0.0001566594,0.001754116,0.08887361],"study_design_scores_gemma":[0.4582979,0.466288,0.06566638,0.00007168062,0.002740237,0.0004881278,0.000136136,0.001660642,0.002372613,0.000118456,0.002091734,0.00006799975],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970752,0.001529538,0.0001577425,0.00006100097,0.00003099582,0.0003116788,0.0003386563,0.00003268991,0.0004625454],"genre_scores_gemma":[0.994639,0.001797201,0.0006849368,0.0002734254,0.0001304955,0.0003429572,0.001264692,0.00001747093,0.0008498129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003109118,"threshold_uncertainty_score":0.01037592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1395606185592076,"score_gpt":0.4803767599733234,"score_spread":0.3408161414141158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}